A study led by the laboratory of Andrea Ablasser has mapped how thousands of genetic changes affect a protein central to immunity, inflammation, cancer, and rare immune diseases.
https://t.co/Wn7XMyUfKb
🦠 Scientists from EPFL show that cholera bacteria can exchange protective genes, including antiviral immune systems, when they live in aquatic environments. The finding helps explain how these pathogens survive viral attacks and evolve in marine habitats.
https://t.co/SKU3CahUrT
Researchers at EPFL, Heidelberg University and Roche have built a human mini-bladder to show how urine composition weakens bladder tissue, helping infections recur even after antibiotics.
https://t.co/lynCfid6dM
New preclinical models for invasive lobular carcinoma have enabled the testing of a promising new drug that effectively slows tumor growth by targeting key features of the disease - opening the door to future clinical trials.
https://t.co/TFWoJeMYUK
Can neurons be rejuvenated to restore memory?
Our scientists show that switching on three “reprogramming” genes in a very small group of memory-related neurons restored memory in aged mice and in mouse models of Alzheimer’s disease.
https://t.co/3dJ4unZDXY
🐻 Scientists from our university and Alaska Pacific University has developed an AI program that can recognize individual bears in the wild, despite the substantial changes that occur in their appearance over the summer season.
https://t.co/vlF48Vm5Mv
Neural interfaces are the winners of the 2026 Queen Elisabeth Prize for Engineering. Nine scientists are honoured, including J.Bloch and G.Courtine (EPF/UNIL/CHUV,) recognized for their development of electronic spinal stimulation technology.
https://t.co/H0PJND1x2o
🧪 A new liver- and gut-targeted oral drug has shown, in a first clinical trial, its ability to reduce triglycerides and other blood lipids - major risk factors for cardiovascular disease, stroke, and pancreatitis.
https://t.co/83EegUMPmt